Skip to main content

Table 2 Patient baseline characteristics (n = 35)

From: Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma

Characteristics N = 35
Median age (range), years 61 (39–76)
Male/female 27 / 8
ECOG / PS  
ECOG 0 21
ECOG 1 13
ECOG 2 1
Primary tumor site  
Gastroesophageal junction 16
Stomach 19
Histology  
well / moderately differentiated 6
poorly differentiaited / signet- ring cell type 21
Disease status  
Locally advanced 19
Metastatic 22
Metastatic sites  
Liver 12
Lymph nodes 11
Peritoneum 4
Lung 5
Bone 2
Other 1
  1. ECOG, Eastern Cooperative Oncology Group.
  2. PS, Performance status.